In his 18 months at Affinity Strategies, David Lee has served as the Executive Director of the United States Bone and Joint Initiative (USBJI) as well as Senior Director of Stakeholder Engagement and Fundraising, leading a team supporting fundraising and partnership...
Who? It’s a big, important story – but it’s easy to get lost in the details. So, let me take a newspaper reporter’s approach here and address essential questions (Who? What? When? Where? Why? How?) about changing relationships between the biopharmaceuticals industry...
We continue to navigate after two years of a pandemic and economic tumult with long-term systemic impacts. As we assessed 2021 and looked to 2022, CLA released our Top 10 list of insights across all industries. Building on this, we decided to look at 2022 through...
We sit poised for an amazing confluence of technology and health care. Technology, in particular, information technology, has helped us make significant advances in care coordination, virtual care and remote patient monitoring. It has also enhanced technical support...
When it comes to value in pricing, it is not about greed.Many associations think that if they discuss pricing, their members will see them as greedy, especially because we are nonprofit organizations. The reality is that our pricing is directly related to our...
Recent Comments